Cambridge Enterprise, the commercialisation unit of Cambridge University, has announced the institution could earn up to £10.7m ($17.6m) from the $95m sale of medtech BlueGnome to US biotech Illumina.
The university has already made £7.7m from the deal, but another £3m could be earned if milestones are met by BlueGnome. The proceeds from the deal will be returned to Cambridge’s seed funds, which will be used to support future spin-out firms.
The windfall comes after the launch of the £50m…
In 2020, Stellenbosch University launched Africa's first-ever university venture fund focused on spinouts — here's how it's reshaping the country.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
